Natera's (NTRA) "Overweight" Rating Reiterated at Stephens :

Stephens reiterated their overweight rating on shares of Natera (NASDAQ:NTRA – Free Report) in a research report released on Tuesday, Benzinga reports. Stephens currently has a $78.00 price target on the medical research company’s stock. A number of other equities research analysts also recently weighed in on the stock. Piper Sandler lowered their target price […]

Related Keywords

United States , American , John Fesko , Piper Sandler , American Century Companies Inc , Invesco Ltd , Wolfe Research , Natera Inc , Norges Bank , Natera Company Profile , Securities Exchange Commission , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Director Gail Boxer Marcus , Street Corp , Century Companies , Natera Daily , Natera , Nasdaq Ntra , Ontra , Medical , Reiterated Rating , Stephens ,